Analysis of risk factors for dry eye disease and effect of diquafosol sodium ophthalmic solution on the tear film after vitrectomy in patients with type 2 diabetes mellitus: a preliminary study
- PMID: 36436170
- DOI: 10.1007/s10792-022-02584-z
Analysis of risk factors for dry eye disease and effect of diquafosol sodium ophthalmic solution on the tear film after vitrectomy in patients with type 2 diabetes mellitus: a preliminary study
Abstract
Purpose: The purpose of this study was to investigate the risk factors of DM associated dry eye syndrome (DMDES) and to explore the effect of diquafosol sodium ophthalmic solution (DQS) on patients with DMDES after vitrectomy.
Methods: Totally 107 patients (107 eyes) received vitrectomy. The data of age, gender, left/right eye, duration of DM, duration of vitrectomy, fasting blood glucose and glycosylated hemoglobin were collected and analyzed for correlation between these factors and DMDES. Postoperatively, DQS was instilled in experimental group and sodium hyaluronate was instilled in control group. The noninvasive breakup time (NIBUT), tear meniscus height (TMH), Schirmer I test (SIT), corneal fluorescence staining score (CFSS) and ocular surface disease index (OSDI) were recorded before vitrectomy and 1, 2 and 3 months after vitrectomy. All data were used for statistical comparison.
Results: Gender, duration of DM and glycosylated hemoglobin were relevant factors of DMDES (P < 0.05). At 1, 2 and 3 months postoperatively, NIBUT and TMH of experimental group were significantly higher than control group (P < 0.05). Postoperatively, CFSS of experimental group was lower than that before vitrectomy, and CFSS at 2 and 3 months after vitrectomy was significantly different between the two groups (P < 0.05). At 1, 2 and 3 months postoperatively, SIT increased in both groups, but there was no significant difference between the two groups (P > 0.05). OSDI was significantly lower in experimental group at 1, 2 and 3 months postoperatively, compared with that of the control group (P < 0.05).
Conclusion: These results suggest that gender, duration of DM and glycosylated hemoglobin are risk factors for DMDES. Postoperative instillation of DQS can improve the tear film quality in patients with DMDES after vitrectomy.
Keywords: Diabetes mellitus; Diquafosol sodium; Dry eye; Tear film; Vitrectomy.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.J Ocul Pharmacol Ther. 2022 Mar;38(2):133-140. doi: 10.1089/jop.2021.0083. Epub 2022 Jan 19. J Ocul Pharmacol Ther. 2022. PMID: 35049373 Clinical Trial.
-
Combination therapy with 3% diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted in situ keratomileusis.Front Med (Lausanne). 2023 Apr 20;10:1160499. doi: 10.3389/fmed.2023.1160499. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37153094 Free PMC article.
-
Temporal changes in parameters associated with tear film stability after instillation of long-acting diquafosol ophthalmic solution in soft contact lens wearers.Jpn J Ophthalmol. 2025 Mar;69(2):308-315. doi: 10.1007/s10384-025-01161-y. Epub 2025 Feb 12. Jpn J Ophthalmol. 2025. PMID: 39937340 Free PMC article. Clinical Trial.
-
Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials.Medicine (Baltimore). 2017 Sep;96(39):e8174. doi: 10.1097/MD.0000000000008174. Medicine (Baltimore). 2017. PMID: 28953672 Free PMC article. Review.
-
Diquafosol ophthalmic solution for dry eye treatment.Adv Ther. 2012 Jul;29(7):579-89. doi: 10.1007/s12325-012-0033-9. Epub 2012 Jul 27. Adv Ther. 2012. PMID: 22843206 Review.
Cited by
-
The effect of transepithelial corneal collagen cross-linking treatment on optical quality of the cornea in keratoconus: 12-month clinical results.Int Ophthalmol. 2024 Mar 18;44(1):146. doi: 10.1007/s10792-024-03089-7. Int Ophthalmol. 2024. PMID: 38499839
-
The Impact of 3% Diquafosol Ophthalmic Solution on Tear Film and Corneal Nerve Density in Patients with Diabetes and Dry Eye Disease: A Randomized Controlled Study.Ophthalmol Ther. 2025 Oct;14(10):2527-2541. doi: 10.1007/s40123-025-01223-x. Epub 2025 Aug 21. Ophthalmol Ther. 2025. PMID: 40839332 Free PMC article.
-
Symptomatic Dry Eye Disease and Associated Factors Among Adult Diabetic Patients in Adare General Hospital, Hawassa City, Southern Ethiopia, 2023.Clin Ophthalmol. 2023 Nov 13;17:3429-3442. doi: 10.2147/OPTH.S433679. eCollection 2023. Clin Ophthalmol. 2023. PMID: 38026606 Free PMC article.
-
Intraocular Lens Power Calculation Formulas-A Systematic Review.Ophthalmol Ther. 2023 Dec;12(6):2881-2902. doi: 10.1007/s40123-023-00799-6. Epub 2023 Sep 12. Ophthalmol Ther. 2023. PMID: 37698825 Free PMC article. Review.
-
Efficacy of 3% diquafosol sodium eye drops at different frequencies in the treatment of dry eye after FS-LASIK.Int J Ophthalmol. 2025 Jun 18;18(6):996-1002. doi: 10.18240/ijo.2025.06.04. eCollection 2025. Int J Ophthalmol. 2025. PMID: 40534800 Free PMC article.
References
-
- International Diabetes Federation (2021) IDF Diabetes Atlas. 10th ed. International Diabetes Federation
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical